No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Apolipoprotein A-I / administration & dosage
-
Apolipoprotein A-I / genetics
-
Apolipoprotein A-I / pharmacology
-
Apolipoprotein A-I / therapeutic use
-
Arachidonate 5-Lipoxygenase / genetics
-
Arachidonate 5-Lipoxygenase / physiology
-
Arteriosclerosis / genetics*
-
Arteriosclerosis / prevention & control
-
Arteriosclerosis / therapy
-
Cohort Studies
-
Coronary Artery Disease / drug therapy
-
Coronary Artery Disease / prevention & control
-
Drug Evaluation, Preclinical
-
Genetic Predisposition to Disease
-
Genetic Testing
-
Genotype
-
Humans
-
Leukotrienes / metabolism
-
Life Style
-
Lipoproteins, HDL / blood
-
Lipoproteins, HDL / genetics
-
Lipoproteins, LDL / blood
-
Lipoproteins, LDL / genetics
-
Methylenetetrahydrofolate Reductase (NADPH2) / genetics
-
Methylenetetrahydrofolate Reductase (NADPH2) / physiology
-
Mice
-
Mice, Inbred C57BL
-
Multicenter Studies as Topic
-
Penetrance
-
Pharmacogenetics
-
Phospholipids / administration & dosage
-
Phospholipids / pharmacology
-
Phospholipids / therapeutic use
-
Polymorphism, Genetic
-
Promoter Regions, Genetic
-
Rabbits
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / pharmacology
-
Recombinant Proteins / therapeutic use
-
Risk
Substances
-
Apolipoprotein A-I
-
Leukotrienes
-
Lipoproteins, HDL
-
Lipoproteins, LDL
-
Phospholipids
-
Recombinant Proteins
-
apolipoprotein A-I Milano
-
Arachidonate 5-Lipoxygenase
-
Methylenetetrahydrofolate Reductase (NADPH2)